Cite
Is There a ‘Right to Try’ Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.
MLA
Jecker, Nancy S. “Is There a ‘Right to Try’ Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.” American Journal of Bioethics, vol. 17, no. 10, Oct. 2017, pp. 70–71. EBSCOhost, https://doi.org/10.1080/15265161.2017.1365196.
APA
Jecker, N. S. (2017). Is There a ‘Right to Try’ Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program. American Journal of Bioethics, 17(10), 70–71. https://doi.org/10.1080/15265161.2017.1365196
Chicago
Jecker, Nancy S. 2017. “Is There a ‘Right to Try’ Experimental Therapies? Ethical Criteria for Selecting Patients With Spinal Muscular Atrophy to Receive Nusinersen in an Expanded Access Program.” American Journal of Bioethics 17 (10): 70–71. doi:10.1080/15265161.2017.1365196.